These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8235696)
1. Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia. Freund M; Hild F; Grote-Metke A; Nowak R; Otremba B; Wörmann B; Koch O; Dohmen M; Kleine HD; Link H Semin Hematol; 1993 Jul; 30(3 Suppl 3):11-3. PubMed ID: 8235696 [No Abstract] [Full Text] [Related]
2. Interferon alfa-2b and cytarabine in chronic myelogenous leukemia. Patel T; Roychowdhury DF N Engl J Med; 1997 Nov; 337(22):1634-5. PubMed ID: 9411231 [No Abstract] [Full Text] [Related]
3. Evolving approaches with interferon alfa in chronic myelogenous leukemia. Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701 [No Abstract] [Full Text] [Related]
4. Initial cytoreduction by mitoxantrone and cytarabine has no impact on the outcome of interferon-alfa-2b therapy in chronic myelogenous leukemia. Nielsen H; Nielsen JL; Karle H Eur J Haematol; 1992 Aug; 49(2):67-70. PubMed ID: 1397243 [TBL] [Abstract][Full Text] [Related]
5. Prolonged hematological remission by mitoxantrone and interferon--alpha-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia. Duru F; Tuncer M; Hiçsönmez G Eur J Haematol; 1993 Sep; 51(3):173-4. PubMed ID: 8405332 [No Abstract] [Full Text] [Related]
15. Pilot study of combined therapy with interferon-alpha, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase. Russo D; Marin L; Bertone A; Tiribelli M; Testoni N; Martinelli G Haematologica; 1999 Feb; 84(2):185-7. PubMed ID: 10091422 [No Abstract] [Full Text] [Related]
16. [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia]. López Hernández MA; Flores-Chapa JD; Trueba Christy E; Borbolla Escoboza JR; Carrillo Rosales T Rev Invest Clin; 1996; 48(4):281-7. PubMed ID: 8966391 [TBL] [Abstract][Full Text] [Related]
17. [Recent progress in therapy for chronic myelogenous leukemia]. Urabe A Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158 [TBL] [Abstract][Full Text] [Related]
18. Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group. Guilhot F Semin Hematol; 1993 Jul; 30(3 Suppl 3):24-5. PubMed ID: 8235700 [No Abstract] [Full Text] [Related]
19. Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemia. Molica S Eur J Haematol; 1992 Feb; 48(2):117-8. PubMed ID: 1547874 [No Abstract] [Full Text] [Related]
20. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia. Kantarjian HM; Talpaz M Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]